faced with a vast array of equipment to choose from and
must be aware of advantages and disadvantages of each
type. Table 49.2 describes some of the phototherapy
devices commonly used in the United States.
a. “Special blue” tubes, such as F20 T12/BB, provide
more irradiance in the blue spectrum than other
tubes and are the most effective fluorescent light
source. (2). The “special blue F20 T12/BB” tubes
provide much greater irradiance than regular blue
tubes, labeled F20T12/B. The flickering glare of the
blue light has been reported to cause giddiness,
nausea, and temporary blurring of vision in nursing
personnel (11). One way to overcome this has been
b. Green/turquoise lamps penetrate the skin to a
greater depth, but the advantage over blue light is
c. Cool white lamps may be inadequate in sufficiently
decreasing total bilirubin levels unless the lights are
positioned in close proximity to the infant (13). As
mentioned previously, this type of light has also
been used together with special blue tubes.
d. Daylight lamps, like cool white lamps, have a wider
wavelength spectrum and are less effective than
a. Halogen spotlight systems utilize single or multiple
metal halide lamps as the light source and can
provide high irradiance over a small surface area
b. These units can generate considerable heat, with the
potential of causing thermal skin injury; therefore,
they must not be in close proximity to the patient.
c. The variable positioning with respect to the distance
expensive than fluorescent bulbs (2).
a. UV-filtered light from a tungsten–halogen bulb
enters a fiberoptic cable and is emitted from the
sides and end of fiberoptic fibers inside a plastic pad.
Fig. 49.1. Guidelines for phototherapy in hospitalized infants of
Hyperbilirubinemia. Management
of hyperbilirubinemia in the newborn infant 35 or more weeks of
gestation. Pediatrics. 2004;114:
Transfusion in Preterm Infants
Total Bilirubin Level (mg/dL/mmol/L)
Gestational Age (wk) Phototherapy Sicka Well
36 14.6 (250) 17.5 (300) 20.5 (350)
32 8.8 (150) 14.6 (250) 17.5 (300)
No comments:
Post a Comment